Erik Heegaard

Erik Heegaard, Chief Medical Officer

Erik received his MD from University of Copenhagen, and subsequently earned a PhD, became a board certified medical specialist, and was awarded a Doctorate Dissertation (DMSc). He also holds an Executive Master of Business Strategy from Copenhagen Business School.

He has held numerous research and clinical positions, and was a medical manager at Statens Serum Institute. Over the past 15 years he has gained profound experience in leadership, project management, clinical development and medical affairs during tenures at Bavarian Nordic, Sandia National Laboratories, Novo Nordisk, Novartis and Seagen.